Back Pain Home > Ultracet and Pregnancy

In animal studies on Ultracet (tramadol/acetaminophen) and pregnancy, the tramadol component of the medication caused decreased birth weight and decreased survival of the newborns when it was given to pregnant rats. However, Ultracet is a pregnancy Category C drug, which means that it may be prescribed to a woman during pregnancy under certain circumstances. If you are taking Ultracet and pregnancy occurs, let your healthcare provider know immediately.

Using Ultracet During Pregnancy: An Overview

Ultracet® (tramadol/acetaminophen) is a prescription pain medication approved for the short-term treatment of pain. At this time, it is not clear whether Ultracet is safe for use during pregnancy.
 

Ultracet and Pregnancy Category C

The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been adequately studied in pregnant humans but that do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a default pregnancy Category C rating.
 
The Tylenol® (acetaminophen) component of this medication is usually considered safe for use during pregnancy. However, the tramadol component may not be safe. In animal studies, tramadol did not increase the risk of birth defects or miscarriages. However, when given to pregnant rats, tramadol caused decreased birth weight and decreased survival of the newborn rats.
 
There have been reports of infant seizures, withdrawal symptoms, and stillbirth possibly related to tramadol. In other countries, tramadol has been studied as a medication to relieve pain during labor and delivery. However, it is not recommended for this use (or for treating pain after delivery) in the United States.
 
However, pregnancy Category C medicines, including Ultracet, may be given to a pregnant woman if her healthcare provider believes that the benefits outweigh any possible risks to the unborn child.
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.